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Abstract
Regular consumption of food enriched in omega3 polyunsaturated fatty acids (v3 PUFAs) has been shown to reduce risk of
cognitive decline in elderly, and possibly development of Alzheimer’s disease. Docosahexaenoic acid (DHA) and
eicosapentaenoic acid (EPA) are the most likely active components of v3-rich PUFAs diets in the brain. We therefore
hypothesized that exposing mice to a DHA and EPA enriched diet may reduce neuroinflammation and protect against
memory impairment in aged mice. For this purpose, mice were exposed to a control diet throughout life and were further
submitted to a diet enriched in EPA and DHA during 2 additional months. Cytokine expression together with a thorough
analysis of astrocytes morphology assessed by a 3D reconstruction was measured in the hippocampus of young (3-month-
old) and aged (22-month-old) mice. In addition, the effects of EPA and DHA on spatial memory and associated Fos
activation in the hippocampus were assessed. We showed that a 2-month EPA/DHA treatment increased these long-chain
v3 PUFAs in the brain, prevented cytokines expression and astrocytes morphology changes in the hippocampus and
restored spatial memory deficits and Fos-associated activation in the hippocampus of aged mice. Collectively, these data
indicated that diet-induced accumulation of EPA and DHA in the brain protects against neuroinflammation and cognitive
impairment linked to aging, further reinforcing the idea that increased EPA and DHA intake may provide protection to the
brain of aged subjects.
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Introduction
A decline in memory and cognitive functions, likely to rely on
hippocampal dysfunction, is considered to be a normal conse-
quence of aging [1]. Memory loss is a prominent health concern
for older individuals (Alzheimer’s Association health national
survey, 2004). Some epidemiological studies suggest a role of long-
chain v3 polyunsaturated fatty acids (LCv3 PUFAs) in slowing
cognitive decline in elderly individuals without dementia [2,3,4,5].
Normal aging is also associated with increased brain in-
flammation characterized by elevated levels of proinflammatory
factors such as proinflammatory cytokines interleukin (IL)-6, IL-1b
and tumor necrosis factor a (TNFa) within the blood and the
hippocampus [6,7,8,9,10,11]. Proinflammatory cytokine expres-
sion is one attribute of glial reactivity, characterized by morpho-
logical and phenotypic modifications of microglia and astrocytes
[12,13,14].
Neuroinflammation, which develops with age, may greatly
contribute to cognitive impairment. Numerous studies have found
a causal link between elevated cytokines levels in the brain and
hippocampus-dependent memory deficits. Indeed, memory im-
pairments induced by infection or stress are reversed by
pharmacological inhibition of cytokine IL-1b [15,16]. The
detrimental role of IL-1b in learning and memory processes is
reinforced by results showing that peripheral as well as in-
tracerebral IL-1b injection impairs long-term memory [17,18]. IL-
6-deficient mice develop less memory impairments and display an
attenuated induction of proinflammatory cytokines in the pyra-
midal cell layer of the hippocampus in response to a bacterial
endotoxin as compared to wild-type mice [19]. In addition, in
adult and aged rodents, these cytokines alter long-term potenti-
ation (LTP), a cellular model of synaptic plasticity that has often
been argued to play a role in learning and memory [20,21,22].
Very recently, study on the temporal relationship between
cognitive aging and molecular changes in the CA1 region has
revealed that neuroinflammatory processes are relevant candidates
for triggering age-related cognitive decline [23]. Interestingly,
inhibition of microglial activation and cytokines production by
minocycline restores hippocampal LTP in aged rats [24] and
improves memory in an animal model of Alzheimer’s disease [25].
All together, these findings support the idea that neuroinflamma-
tion is a decisive component of cognitive disorders in aged subjects.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36861Thus, neuroinflammation is a good target to limit development
of cognitive deficits with age [26]. LCv3 PUFAs, docosahexaenoic
acid (DHA) and eicosapentaenoic acid (EPA) have anti-inflam-
matory properties [27] Reinforcing these data, we have recently
demonstrated that DHA potently blocked in vitro endotoxin-
induced cytokines production by microglial cells [28] and that
a decrease in its brain level by dietary means [29] potentiated
endotoxin-induced IL-6 production in the mouse hippocampus
[30]. Very recently, we demonstrated that lifelong consumption of
a control diet well-balanced in v3 and v6 PUFAs (in form of a-
linolenic acid, a-LNA and linoleic acid, LA) increased brain DHA
level as compared to an a-LNA-deficient diet [10]. However,
lifelong consumption of the control diet was not sufficient to
protect aged mice from proinflammatory cytokines expression and
spatial memory decline [10].Interestingly, dietary intake of DHA
and EPA has been shown to be involved in pathways likely to
influence cognitive processes in elderly subjects and aged rodents
[31,32,33,34,35,36,37]. However its effect on age-related neuroin-
flammatory processes has been poorly evaluated.
In this study, we hypothesized that a supplementation with the
LCv3 PUFAs (DHA and EPA) over a two-month period may
protect the brain from an uncontrolled inflammatory response and
consequent cognitive decline. We demonstrated here that a two-
month supplementation with dietary sources of LCv3PUFAs
improved spatial memory and prevented from age-related
neuroinflammatory processes.
Materials and Methods
Animals and Diets
All animal experiments were conducted according to the INRA
Quality Reference System, and to relevant French (Directive 87/
148, Ministe `re de l’Agriculture et de la Pe ˆche) and international
(Directive 86/609, November 24th 1986, European Community)
legislation. This study was approved by INRA. Protocols were in
keeping with protocols approved by Re ´gion Aquitaine Veterinary
Services (Direction De ´partementale de la Protection des Animaux,
approval ID: A33-063-920). Every effort was made to minimize
suffering and the number of animal used. All experiments were
performed with C57Bl6/J mice obtained from Charles River
(Arbresle, France). They were maintained under standard housing
conditions on corn cob litter in a temperature- (2361uC) and
humidity-controlled (40%) animal room with a 12 h light/dark
cycle (7:00–19:00), with ad libitum access to food and water. Mice
were raised and housed at the laboratory in groups of three in
transparent polycarbonate cages. Mice were given experimental
diets ad libitum (pellets prepared by UPAE-INRA, Jouy-en-Josas,
France replaced daily) as previously described [10,29,38,39] (see
Table 1 and 2). To protect fatty acids (FAs) from oxidation, 20 g/
kg of DL-a-tocopheryl acetate was added to the diets (see table 1).
The source of EPA and DHA is tuna oil [40]. Pellets were stored at
+4uC and FA composition was regularly controlled via gas
chromatography analyses of organic extracts from manufactured
food pellets. After mating, C57BL/6J female mice were submitted
to an essential fatty acid (EFA) diet containing a mixture of
rapeseed oil (rich in a-LNA), high-oleic sunflower oil and palm oil
resulting in an a-LNA/LA ratio of J (control diet) throughout
gestation and lactation as previously described [10,29,30]. Male
offspring were fed with the same diet as their dam until they were
1 month or 20 months old; thereafter, they were either maintained
on the control diet or changed on an isocaloric LCv3 PUFA-
supplemented diet containing a mixture of rapeseed oil, high-oleic
sunflower oil, palm oil and tuna oil resulting in a 10% EPA and
7% DHA diet (LCv3 diet) for 2 additional months (for diet
composition, see Table 1 and Table 2). This period of time was
chosen on the basis of previous studies showing that a 2 to 3-
month supplementation with a diet enriched in LCv3 increases
DHA levels in neural tissues [41] and retina [40].
A total of 54 mice divided in two cohorts were used for the
following experiments. One cohort was used for behavioral
measures (control diet: n=7/young mice and n=7/old mice;
LCv3diet: n=9/young mice and n=7/old mice), c-Fos immu-
nohistochemistry (6 mice were randomly chosen from each group)
and morphometric analysis of astrocytes (3 mice were randomly
chosen from each group). A second cohort (n=6 per group)was
used for the assessment of plasmatic cytokines by BioPlex,
hippocampus-located cytokines by RT-PCR and cortical FAs
levels.
Behavioral measures
Behavioral testing took place in the morning (between 8:00 AM
and 11:00 AM). Mice were handled for 5 min every day for two
weeks prior the experiments. All the experiments were performed
in an adjacent room to the animal facility under 78 lux of
illumination.
Spatial recognition. Spontaneous spatial recognition in the Y-
maze was used as a hippocampus-dependent test in a two-trial
procedure as previously described [10,42]. The apparatus used
was a Y-shaped maze made of gray plastic. Each arm was 34 cm
long, 8 cm wide and 14 cm high. Extra-maze visual cues were
placed around the testing room and kept constant during the test.
All arms of the maze being identical, discrimination between
novelty and familiarity was only based on the different aspects of
the testing room. The floor of the maze was covered with soiled
sawdust coming from the home cages of several animals, and was
mixed between sessions in order to eliminate olfactory cues. In the
first trial, one arm of the Y-maze was closed with a guillotine door
and mice were allowed to visit the two other arms for 5 min. After
a 5-min inter-trial interval (ITI), mice were placed again in the
start arm for the second trial and allowed to freely explore all three
arms for 5 min. Start and closed arms were randomly assigned for
each mouse. Preference for novelty was also assessed using
a minimal ITI between acquisition and retrieval (less than 1 min).
Table 1. Composition of the diets (g/kg diet).
Ingredient Amount
Casein 180
Cornstarch 460
Sucrose 230
Cellulose 20
Fat
1 50
Mineral mix
2 50
Vitamin mix
3 10
1: for detailed composition, see Table 2.
2: composition (g/kg): sucrose, 110.7; CaCO3, 240; K2HPO4, 215; CaHPO4, 215;
MgSO4,7H2O, 100; NaCl, 60; MgO, 40; FeSO4,7H2O, 8; ZnSO4,7H2O, 7;
MnSO4,H2O, 2; CuSO4,5H2O, 1; Na2SiO7,3H2O, 0.5; AlK(SO4)2,12H2O, 0.2; K2CrO4,
0.15; NaF, 0.1; NiSO4,6H2O, 0.1; H2BO3, O.1; CoSO4,7H2O, 0.05; KIO3, 0.04;
(NH4)6Mo7O24,4H2O, 0.02; LiCl, 0.015; Na2SeO3, 0.015; NH4VO3, 0.01.
3: composition (g/kg): sucrose, 549.45; retinyl acetate, 1; cholecalciferol, 0.25;
DL-a-tocopheryl acetate, 20; phylloquinone, 0.1; thiamin HCl, 1; riboflavin, 1;
nicotinic acid, 5; calcium pantothenate, 2.5; pyridoxine HCl, 1; biotin, 1; folic
acid, 0.2; cyanobalamin, 2.5; choline HCl, 200; DL-methionin, 200; p-
aminobenzoic acid, 5; inositol, 10.
doi:10.1371/journal.pone.0036861.t001
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deficits and to verify that all groups performed more visits to the
novel arm when mnemonic demand was minimal.We compared
the time spent exploring the novel and the familiar arm during the
first 3 minutes of the second trial.
Object recognition. The test was performed as previously
described [42]. A week before the acquisition phase (trial 1), mice
were acclimatized to a 40640 cm box made of white-coated
plywood with 16 cm high walls for 15 min per day. The floor of
the box was covered with corn cob litter which was mixed between
trials in order to remove olfactory cues. During the 10 min of the
trial 1, two identical plastic blocks with a particular shape and
color were presented to the animal. At the end of the trial 1, the
mouse was replaced in its home cage for a 1 h inter-trial interval
(ITI) and one of the familiar blocks was replaced by a novel object
with a different shape and color to test for memory retention.
During the retrieval phase (trial 2), animals had free access to the
familiar and novel blocks for 5 min. Object’s exploration was
defined as the mouse pointing its nose towards the object and/or
touching it with the nose. Analysis was based on the time spent
exploring the novel and the familiar objects during the 5 min of
trial 2.
Tissue processing
After transcardiac perfusion with PBS (pH 7.4), followed by 4%
paraformaldehyde, brains were removed, post-fixed for 4 h,
cryoprotected in 30% sucrose for 24 h, snap frozen in liquid
nitrogen, and stored at 280uC before sectioning. Free-floating
30 mm coronal sections through the hippocampus (from -0.9 mm
to -3.1 mm relative to bregma) were collected on a cryostat for
immunohistochemistry.
c-Fos immunohistochemistry and quantification
C-fos imaging was used as a neuronal activity reporter to map
neurons activated in the hippocampus after the memory test
[43,44]. In aged mice submitted to memory tests, c-Fos marker
decrease in the hippocampus is known to predict spatial memory
impairment [45,46]. To analyze cellular activation in the
hippocampus of mice under study, we measured the expression
of c-Fos by immunohistochemistry as previously described [42].
Mice were sacrificed by injecting a lethal dose of pentobarbital
90 min after the acquisition phase of the spatial recognition task
(Y-maze group) or after a free exploration test (control group).
This delay was chosen based on previous data showing that
90 min corresponds to the c-Fos protein expression peak in the
hippocampus of mice subjected to spatial memory tests [42]. Mice
in the Y-maze group were subjected to two 5 min tests in the Y-
maze with a 5 min ITI, whereas control mice were allowed to
freely explore a new cage in the same room and for the same
amount of time as their spatially-trained counterparts (i.e. two
5 min periods with a 5 min ITI). This control condition allows
assessment of activation resulting from exploratory behavior,
sensorimotor stimulation, stress, and other factors not related to
the spatial task. Thus, the difference between these two profiles,
i.e. activation induced in the Y-maze group and in the control
group, reflects learning-specific changes.
To analyze c-Fos expression, sections were incubated overnight
at room temperature (RT) in rabbit polyclonal antiserum raised
against c-Fos (Santa Cruz Biotechnology, Santa Cruz, CA), diluted
1:1000 in Tris Buffered Saline (TBS) containing 0.3% Triton X-
100, 2% donkey serum and 1% bovine serum albumin (BSA),
before being incubated for 2 h with biotinylated donkey anti-
rabbit antibody (1:1000; Amersham Pharmacia Biotech Europe,
Freiburg, Germany). Sections were then incubated for 2 h with
avidin-biotin peroxidase complex (1:1000; Vectastain ABC kit,
Vector laboratories, Burlingame, CA), and labeling was revealed
Table 2. Fatty acid composition of the dietary lipids.
Diet Control LCv3
% wt of total fatty acids g/kg diet % wt of total fatty acids g/kg diet
16:0 22.6 11.3 20.0 10.0
18:0 3.3 1.65 3.9 1.95
other saturated FAs 1.8 0.9 6.6 3.3
total saturated FAs 27.7 13.85 30.5 15.25
18:1v9 57.9 28.95 22.6 11.3
18:1v7 1.5 0.75 4.9 2.45
other monounsaturated FAs 0.6 0.3 6.7 3.35
total monounsaturated FAs 60.0 30.0 34.2 17.1
18:2 v6 (LA) 10.7 5.35 15.2 7.6
18:3 v3 (ALA) 1.6 0.8 0.9 0.45
20:5 v3 (EPA) n.d. n.d. 10.9 5.45
22:5 v3 (DPA) n.d. n.d. 1.1 0.55
22:6 v3 (DHA) n.d. n.d. 7.2 3.6
Total v3 PUFAs 1.6 0.8 20.1 10.05
total PUFAs 12.3 6.15 35.3 17.65
v6/v3 6.7 6.7 0.8 0.8
FAs, fatty acids; LA, linoleic acid; ALA, a-linolenic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid, PUFAs, polyunsaturated
fatty acids.
doi:10.1371/journal.pone.0036861.t002
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method [47]. Sections were then mounted onto gelatin-coated
glass slides. Negative controls in which the primary antibody was
omitted did not show any immunolabeling.
Brain sections were examined under a light microscope with
a 10X objective (Nikon Eclipse E 400, Nikon Corporation,
Champigny-sur-Marne, France) and images were captured by
a high-resolution digital Nikon DXM 1200 camera (Nikon
Corporation). Camera aperture, magnification, light power, and
exposure time were fixed for all images. Images were generated
and saved using ACT-1 software (Nikon Corporation, Cham-
pigny-sur-Marne, France). Quantification of c-Fos immunoreac-
tive cells was performed with the NIH-imaging software Scion
Image (Frederick, MD). The mean number of c-Fos positive cells
was quantified in all consecutive sections containing the hippo-
campus (5–6 sections per mouse) in both hemispheres.
GFAP immunostaining, 3D-reconstruction and
morphometric analysis of astrocytes
To analyze astrocyte morphology, fluorescent labeling for
GFAP was carried out in the hippocampus as previously described
[48][38]. Sections were incubated overnight at RT with a rabbit
anti-cow GFAP antibody (1:1000) in PBS containing 3% goat
serum (Sigma Aldrich Corporation, Saint Louis, MI) and 0.3%
Triton X-100. After rinsing, sections were incubated for 2 h with
Alexa 594-conjugated goat anti-rabbit antibody (1:1000; Molec-
ular probes, Eugene, OR). Sections were then rinsed in PBS,
mounted and coverslipped withVectashield mounting medium
(Abcys, Paris, France). A series of images with an interval of
0.5 mm in the z-axis was captured with a confocal microscope
(Leica DMR upright TCS SP2 AOBS) equipped with a HeNe
laser, a 63X oil-immersion lens and a 3.10X zoom in the dentate
gyrus (DG), CA1 and CA3 of the median hippocampus. For each
region, 3 confocal images of GFAP fluorescence from each
hemisphere were acquired randomly from 3 sections/mouse.
Morphology of astrocytes was analyzed using the 3-D reconstruc-
tion software IMARIS. Processes length and diameter were
measured using the ‘‘filament tracer’’ program (see Figure S1).
BioPlex cytokine measures
Blood samples from mice were collected in EDTA-coated vials
and centrifuged for 15 min at 3000 g at 4uC, aliquoted and stored
at 280uC. Biorad bioplex kits were used for all assays (BioRad,
France) as previously described [10]. All samples were run in
duplicate and were assayed for IL-1b, IL-6 and TNFa according
to the manufacturer’s instructions. Results were expressed in pg/
ml. The detection range was 0.35–5695.9 pg/ml.
Real-time PCR
Mice were sacrificed by injection of a lethal dose of
pentobarbital immediately after completion of behavioral testing,
and transcardially perfused with Phosphate Buffered Saline (PBS).
Hippocampi were quickly removed and frozen on dry ice. Two mg
of total RNA obtained from each brain area were reverse
transcribed with Moloney Murine Leukemia Virus reverse
transcriptase (Invitrogen, Cergy-Pontoise, France). Quantitative
PCR was then performed using the Applied Biosystems Assay-on-
Demand Gene Expression Products protocol, as previously
described [30]. Briefly, cDNAs for IL-6, IL-1b, TNFa, CD11b,
GFAP and a housekeeping gene (b2-microglobulin) were amplified
by PCR using an oligonucleotide probe with a 59 fluorescent
reporter dye (6-FAM) and a 39 quencher dye (NFQ). Fluorescence
was measured using an AB 7500 Real-Time PCR system (Applied
Biosystems, Foster city, CA) and final quantification was carried
out using the comparative threshold (Ct) method as previously
described [30,42]. For each experimental sample, difference
between target gene and housekeeping gene Ct values (DCt) was
used to normalize for differences in the amount of total nucleic
acid added to each reaction and in the efficiency of the RT step.
Values were then expressed as relative fold change (RFC) of the
mean DCt value obtained for the group of control mice (free
exploration behavior, see above) (calibrator DCt) by subtracting
DCt for each experimental sample from the calibrator DCt
(=DDCt). The amount of target gene (linear value) normalized to
the housekeeping gene and relative to the calibrator was de-
termined by 2
2DDCt.
Analysis of fatty acid levels in brain lipids
Analysis of fatty-acid levels in brain lipids was carried out in the
brain in order to minimize the number of animals (the same mice
were used for the RT-PCR measurement of cytokines in the
hippocampus). Lipids were extracted from the brain of 3- and 22-
month old mice and fatty acids were transmethylated according to
Morrison and Smith. Fatty acid methyl esters were analyzed on
a Hewlett-Packard 5890 series II gas chromatograph equipped
with a split/splitless injector, a flame ionization detector (Palo
Alto, CA), and a CPSil88-silica capillary column
(100 m60.25 mm i.d., film thickness 0.20 mm, Varian, Les Ulis,
France). The injector and the detector were maintained at 250uC
and 280uC, respectively. Hydrogen was used as a carrier gas (inlet
pressure 210 kPa). The oven temperature was fixed at 60uC for
1 min, increased to 85uC at a rate of 3uC/min and then to 190uC
at a rate of 20uC/min, and maintained at this temperature for
65 min. Fatty acid methyl esters were identified by comparison
with commercial standards.
Statistical analysis
All data are expressed as the mean 6 SEM. A three-way
analysis of variance (ANOVA) with age (young vs. aged) and diet
(control vs. LCv3) as between-subjects factors and arm or object
(novel vs. familiar) as the within-subjects factor was performed for
spatial or object recognition analyses. Specific comparisons
between novel and familiar (arms or objects) were assessed by
paired Student’s t-tests. Specific comparisons between young and
aged mice or control and LCv3 mice were assessed by unpaired
Student’s t-tests. PUFA brain levels, c-Fos quantification, RT-
PCR measurements and astrocytic processes length were analyzed
by two-way ANOVAs (age x diet). If a significant interaction was
revealed, ANOVAs were followed by Fisher LSD post-hoc
comparisons. Relationship between the number of c-Fos positive
cells and the recognition score (novel object exploration/
familiar+novel object exploration) was evaluated using Bravais-
Pearson’s correlation tests. For all results, a p-value,0.05 was
considered as significant.
Results
1) Short-term dietary supplementation with LCv3 PUFAs
increases DHA and EPA levels in the brain of aged mice
We first investigated the impact of diets on LC PUFA levels in
the brain of young and aged mice (Table 3). Arachidonic acid (AA)
level was significantly increased according to age (F(1,13)=38.27,
p,0.001) and diet, with no significant effect of the interaction
between age and diet. Conversely, DHA and EPA levels were
significantly decreased with age (EPA: F(1,13)=57.42, p,0.001
and DHA: F(1,13)=19.44, p,0.001) and increased after con-
sumption of fish oil (EPA: F(1,13)=572.02, p,0.001 and DHA:
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(EPA F(1,13)=32.30; p=0.0001 and DHA F(1,13)=6.88;
p,0.05). Post-hoc analysis further revealed a significant increase
of EPA and DHA in the brain of aged mice fed with the fish oil
diet as compared to those fed with the control diet (p,0.001).
These changes resulted in significant differences in LCv6/
LCv3ratio (age effect: F(1,13)=39.71; p,0.001). In addition,
delta 5 desaturase ratio (AA/dGLA) was significantly increased
with age (F(1,13)=98.10; p,0.001) and diet (F(1,13)=24.76;
p,0.001) with no significant diet x age interaction. AA is the
precursor of proinflammatory lipidic derivates, while dGLA and
EPA are precursors of anti-inflammatory lipidic derivates [49].
The ratio of (dGLA+EPA)/AA is significantly decreased with age
(F(1,13)=139.64; p,0.001) and increased with diet
(F(1,13)=66.00; p,0.001) with a significant age * diet interaction
(F(1,13)=8.73; p,0.05). Post hoc analysis further revealed that
this ratio was significantly higher in aged mice fed with the LCv3
diet as compared to those fed with the control diet (p,0.05).
2) Spatial memory deficits in aged mice are reduced by
a 2-month dietary supplementation with LCv3 PUFAs
Spatial memory performance was assessed using a Y-maze test
with a 5-min inter-trial interval (ITI) in adult and aged mice fed
with the control or the LCv3 diet [10]. Spatial memory
performances were significantly impaired with age and diet
(Fig. 1A). A three-way ANOVA (age x diet x arm) revealed
a significant effect of arm (F(1,52)=31.7, p,0.001), and a signif-
icant interaction between age and arm (F(1,52)=16.7, p,0.001)
and diet and arm (F(1,52)=5.7, p,0.05). Further analyses
revealed that aged mice given the LCv3 diet significantly
distinguished between the novel and the familiar arm (paired-t-
test, t(8)=4.8, p,0.01), unlike aged control mice, which exhibited
a random exploration of the two arms (p=0.55). We did not
observed a difference in the time spent in the starting arm between
aged mice fed with the control diet and those fed with the LCv3
diet (p=0.159, data not shown). In order to evaluate whether the
impairment revealed in aged mice fed with the control diet was
a memory deficit or a performance deficit related to motivational
alterations, animals underwent a spatial recognition test with
Table 3. Brain fatty acid composition.
Young Aged Statistical effects
Control diet
n=4
LCv3 diet
n=4
Control diet
n=4
LCv3 diet
n=4 Diet effect Age effect Diet x Age
% of total fatty acids
16:0 14.360.28 19.560.35 14.060.80 18.660.20 ,0.001 ,0.05 NS
18:0 16.860.51 18.160.17 16.960.54 17.060.69 ,0.05 NS NS
Total saturated fatty acids 34.860.73 39.060.50 33.860.78 36.960.53 ,0.001 ,0.01 NS
16:1 v7 0.560.01 0.660.02 0.560.05 0.760.06 ,0.001 ,0.05 NS
18:1 v9 20.260.59 17.860.27 21.760.30 19.160.36 ,0.001 ,0.001 NS
18:1 v7 4.560.03 3.560.03 3.860.04 3.460.02*** ,0.001 ,0.001 ,0.001
Total monounsaturated fatty
acids
34.160.93 25.360.45 34.561.72 27.160.43 ,0.001 NS NS
18:2 v6 0.460.04 0.260.00 0.460.03 0.360.01** ,0.001 NS ,0.01
20:2 v6 0.260.01 0.160.00 0.160.01 0.0560.01*** ,0.001 ,0.001 ,0.001
20:3 v6 (dGLA) 0.560.02 0.460.01 0.460.02 0.360.02 ,0.001 ,0.001 NS
20:4 v6 (AA) 5.560.24 5.860.16 6.260.32 6.660.23 ,0.05 ,0.001 NS
22:4 v6 2.360.03 1.360.03 2.260.04 1.760.13*** ,0.001 ,0.001 ,0.001
22:5 v6 0.160.02 0.260.01 0.160.01 0.160.02 ,0.01 ,0.001 NS
Total v6 fatty acids 9.260.29 8.060.18 9.560.36 9.260.35 ,0.001 ,0.001 ,0.05
20:5 v3 (EPA) 0.160.01 0.460.01 0.0560.01 0.260.04*** ,0.001 ,0.001 ,0.001
22:5 v3 0.260.01 0.660.03 0.2+0.02 0.460.05*** ,0.001 ,0.001 ,0.001
22:6 v3 (DHA) 9.260.65 15.960.34 8.760.87 13.760.46*** ,0.001 ,0.001 ,0.05
Total v3fatty acids 9.560.66 16.960.36 8.960.89 14.360.53*** ,0.001 ,0.001 ,0.05
Total v6+v3 fatty acids 18.660.94 24.960.38 18.461.22 23.560.53 ,0.001 NS NS
Total DMA 12.560.73 10.760.18 13.360.31 12.460.70 ,0.001 ,0.001 NS
v6/v3 0.9760.04 0.4860.02 1.0760.07 0.6460.04 ,0.001 ,0.001 NS
LC v6/LC v3 0.960.04 0.560.02 1.060.07 0.660.04 ,0.001 ,0.01 NS
AA/dGLA 11.660.84 14.260.68 17.161.33 20.561.65 ,0.001 ,0.001 NS
(dGLA+EPA)/AA 0.1060.01 0.1460.01 0.0760.00 0.0960.01* ,0.001 ,0.001 0.01
dGLA: dihomo-gamma-linolenic acid (20:3 v6); AA: arachidonic acid (20:4 v6); EPA: eicosapentaenoic acid (20:5 v3); DHA: docosahexaenoic acid; DMA: dimethyl acetal;
LC v6: long chain v6 (20:2 v6+20:3 v6+20:4 v6+22:4 v6+22:5 v6); LC v3: long chain v3 (20:5 v3+22:5 v3+22:6 v3); NS: not significant.
***p,0.001 as compared to aged control diet;
**p,0.01 as compared to aged control diet;
*p,0.05 as compared to aged control diet.
doi:10.1371/journal.pone.0036861.t003
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demand was minimal, all mice exhibited a clear preference for the
novel arm (arm effect, F(1,52)=135.6, p,0.0001; no effect of diet,
F(1,52)=0.003, n.s., or age, F(1,52)=0.15, n.s., or interaction arm
x diet, F(1,52)=0.003, n.s., or arm x age F(1, 52)=0.003, n.s.;
data not shown).
Mice were submitted to the object recognition test which is
based on the spontaneous tendency of rodents to spend more time
exploring a novel object than a familiar one. This test is known to
be hippocampus-independent [50]. A three-way ANOVA (age x
diet x object) revealed a significant effect of object (F(1,52)=52.2,
p,0.001) and a significant interaction between age and object
(F(1,52)=21.9, p,0.001) (Fig. 1B). Interestingly, even if aged mice
spent significantly less time exploring the new object as young mice
did, all mice recognized the novel object compared to the familiar
one, whatever the diet or the age of animals (paired-t-test: young
control mice t(6)=5.3, p,0.01; young LCv3 mice t(7)=5.6,
p,0.01; aged control mice t(9)=4.5, p,0.01; aged LCv3 diet
t(7)=2.8,p,0.05).
C-fos is expressed in an activity-dependent manner and has
been used as a marker for activated neurons involved in learning
and memory processes. In particular, we have previously shown
that c-Fos is activated in the CA1 and DG, but not in the CA3
region of the hippocampus after a Y-maze task [42]. In addition, c-
Figure 1. Spatial and object recognition memory. (A) Time spent (in sec) in the novel or the familiar arm after a 5-min ITI in 3-month-old
(young) and 22-month-old (aged) mice fed with the control diet or the LCv3 diet for 2 months. (B) Time spent (in sec) in the novel or the familiar
object after a 1-hr ITI in 3-month-old (young) and 22-month-old (aged) mice fed with the control diet or the LCv3 diet for 2 months. *** p,0.001, **
p,0.01, * p,0.05.
doi:10.1371/journal.pone.0036861.g001
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this task [42]. We therefore measured c-Fos expression in the DG,
CA1 and CA3 regions of the hippocampus of young and aged
mice fed with the control diet or the LCv3 diet after a Y-maze task
(5 min ITI) or under control conditions (free exploration behavior)
(Fig. 2A, 2B). In the CA1, CA3 and DG regions, no significant
difference between age or diet was revealed under control
conditions (free exploration behavior, an average of 8 to 11 c-
Fos-positive cells per animal for DG and CA1 and an average of
30 c-Fos-positive cells for CA3 per animal, data not shown). After
the Y-maze task, c-Fos was activated in the DG and CA1, but not
in the CA3 (Fig. 2A, 2B) as previously described [42]. A two-way
ANOVA did not reveal a significant effects of age (F(1,20)=2.5,
n.s.) or diet (F(1,20)=0.37, n.s.), but revealed a significant
interaction between age and diet (F(1,20)=6.2, p,0.05) in the
DG. Post-hoc analysis further revealed a significant increase of Y-
maze-induced c-Fos positive cells in the DG region of aged mice
(Fisher LSD, p,0.01) fed with the LCv3 diet as compared to
control diet (Fig. 2A, 2B). However, the impact of Y-maze
exposure differed across hippocampal regions. Indeed, a two-way
ANOVA revealed an age effect (F(1,20)=37.02, p,0.0001) and
a diet effect (F(1,20)=9.67, p,0.01) with no interaction
(F(1,20)=0.21, n.s.), in the CA1 region (Fig. 2A, 2B).
We further examined the relationship between c-Fos expression
in the brain after the Y-maze task and spatial memory
performances in this latter. As shown in Fig. 2C, c-Fos expression
in the hippocampus was positively correlated to cognitive
performances, in the DG and the CA1 (DG, r=0.45, p,0.05;
CA1, r=0,72, p,0.001) but not in the CA3 (CA3: r=20.01,
n.s.).
3) Neuroinflammatory processes are reduced by a 2-
month dietary supplementation with LCv3 PUFAs in the
hippocampus of aged mice
DHA potently reduces microglia-dependent activation and
proinflammatory cytokines production in microglia [28]. Proin-
flammatory cytokines overproduction in the brain is linked to glial
cells activation, in particular to microglia and astrocytes. One
attribute of microglial activation is the overexpression of microglia-
associated epitope CD11b [14]. With regard to astrocytes, the
morphological alterations associated with aging are described as
astrogliosis, a term that covers a rise in the expression of the
astrocytic intermediate filament glial fibrillary acidic protein
(GFAP). GFAP is a marker of astrogliosis that is elevated with
age in mammals and is increased under inflammatory conditions
[51]. Here, we investigated the effects of a short-term dietary
supplementation with LCv3 PUFAs on CD11b, GFAP, IL-1b, IL-
6 and TNFa mRNA expression in the hippocampus of aged mice.
As shown in Fig. 3A, CD11b mRNA expression was significantly
higher in the hippocampus of aged mice than in young mice (age
effect: F(1,20)=12.5, p,0.01; Fisher LSD, p,0.05). A LCv3
PUFA-supplemented diet significantly decreased mRNA levels of
CD11b in aged mice (diet effect: F(1,20)=4.9, p,0.05; Fisher
LSD, p,0.05- interaction age x diet: F(1,20)=4.47, p,0.05).
GFAP mRNA expression increased with age (age effect:
F(1,20)=26.3, p,0.0001) but was not affected by diet (Fig. 3A).
Results presented in Fig. 3A revealed a significant increase in
TNFa, IL-6 and IL-1bmRNA expression throughout aging (age
effect: F(1,20)=85.2, p,0.0001; F(1,20)=24.6, p,0.0001 and
F(1,20)=4.7, p,0.05 respectively). Post-hoc analyses further
revealed that TNFa mRNA (Fisher LSD, p,0.001) and IL-6
mRNA (Fisher LSD, p,0.05) expression was significantly de-
creased to basal levels seen in young mice when aged mice were
fed with the LCv3 diet, contrary to aged mice fed with the control
diet (diet effect: F(1,20)=47.6, p,0.001 for TNFa; F(1,20)=5.3,
p,0.05 for IL-6) (Fig. 3A).
IL-1b expression was significantly higher in the plasma of aged
mice compared to young mice (age effect: F(1,15)=8.7, p,0.01;
Fisher LSD, p,0.05) (Fig. 3C). This was significantly reversed by
aL C v3 PUFA-supplementation in aged mice (diet effect:
F(1,15)=12, p,0.01; Fisher LSD, p,0.01; interaction age x diet:
F(1,15)=3.5, p=0.08). A two-way ANOVA revealed an increase
in TNFa expression with age (age effect: F(1,15)=5.3, p,0.05)
whereas no effect of age or diet in IL-6 plasma levels was found in
the four groups of mice (age effect: F(1,15)=1.7, n.s.; diet effect:
F(1,15)=2.6, n.s.) (Fig. 3C).
In reactive astrocytes, GFAP labeling underlay an increase in
the number, length and thickness of processes leaving the soma,
leading to a hypertrophic phenotype [12,13].
We then determined the effect of LCv3 PUFAs on astrocytes
morphology in both young and aged mice. A quantitative
morphometric analysis of GFAP-immunolabeled astrocytes has
previously been used to demonstrate the occurrence of reactive
astrocytes in the hippocampus of aged mice [52]. We analyzed
astrocytic processes length by 3D-reconstruction analysis of GFAP
immunofluorescence and subsequent quantification (Fig. 4A, 4B).
In the DG of young mice, astrocytes had long processes extending
from the hilus to the granule cell layer (Fig. 4A, left panel). In aged
mice, astrocytes morphology was more ‘‘bushy-like’’ with shorter
processes (Fig. 4A, central panel), as further revealed by
quantification of astrocytic processes length (age effect:
F(1,206)=70.91, p,0.0001; Fisher LSD, p,0.0001) (Fig. 4B).
With LCv3 PUFA supplementation, processes length in the DG of
aged mice was partially restored (diet effect: F(1,206)=5.88,
p,0.05; age x diet interaction: F(1,206)=57.34, p,0.0001 and
Fisher LSD, p,0.0001) (Fig. 4A, right panel and 4B). Astrocytes
had a more stellate shape in the CA1 and CA3 regions of both
young and aged mice. A 2-month LCv3 PUFA supplementation
had an effect on astrocytic processes length, as revealed by two-
way ANOVA, in the CA1 (age effect: F(1, 180)=9.43, p,0.01;
age x diet interaction: F(1,180)=4.34, p,0.05) and CA3 (age
effect: F(1,192)=9.94, p,0.01; diet effect: F(1,192)=7, p,0.01;
age x diet interaction: F(1,192)=9.54, p,0.01). Post-hoc analysis
further revealed that LCv3 PUFAs significantly increased the
length of astrocytic processes in aged mice (Fisher LSD: young
mice fed with control diet vs. aged mice fed with LCv3 diet,
p,0.01 for CA1 and p,0.0001 for CA3; young mice vs. aged
mice fed with LCv3 diet, p,0.01 for CA1 and p,0.0001 for
CA3; aged mice fed with control diet vs. aged mice fed with LCv3
diet, p,0.05 for CA1 and p,0.001 for CA3) (Fig. 4A, 4B).
Discussion
The work presented here provides direct in vivo evidence of anti-
inflammatory and protective action of LCv3 PUFA supplemen-
tation on age-associated cognitive decline. Mice fed with the
control diet, displayed poorer working memory performances with
age. This was accompanied by an increase in the expression of
CD11b and GFAP as well as mRNA levels of proinflammatory
cytokines in the hippocampus. The increase in GFAP mRNA
expression was associated with the appearance of shorter astrocytic
processes in the DG, but not in the CA1 and CA3 as revealed by
GFAP immunofluorescence. A 2-month dietary supplementation
with fish oil in aged mice increased brain levels of DHA and
significantly reduced mRNA levels of TNFa, IL-6 and CD11b.
While GFAP expression was not reduced by the supplementation,
the length of astrocytic processes in the DG was restored in the
CA1 and CA3. In addition, working memory was improved by the
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provide new insight into the use of LCv3 PUFA supplementation
in the elderly to limit development of neuroinflammation and
cognitive impairment.
In the present study, we formulated 2 diets in order to provide
different levels of DHA to the brain. In this work, the LCv3 PUFA
supplementation was given for 2 months to mice fed throughout
life with the control diet. This was of importance that the control
and the LCv3 diets contained the same total amount of fat,
therefore avoiding the possibility of a general effect of lipids. We
previously showed that the long-term consumption of the control
diet provided DHA to the brain of both young and aged mice
[10,29,30]. We further found that adult and aged mice fed with
the LCv3 PUFAs for 2 months had a higher DHA level in the
brain compared to mice fed with the control diet. This is in
agreement with previous studies showing that short-term con-
sumption of a DHA-enriched diet in form of fish oil diet potently
increased brain DHA level in young [53] and aged mice
[31,54,55]. It is of importance that EPA was also increased in
the brain of aged mice fed with LCv3 PUFAs, although the total
levels remained very low as compared to those found for DHA.
EPA increase has been recently reported in the brain of rats fed
with a highly enriched EPA diet [56], however whether this
increase was linked to preformed EPA incorporation in the brain
or to a metabolic conversion of a-LNA remains to be determined.
Increased brain EPA and DHA levels in the aged brain were
associated to the decrease in neuroinflammatory processes in the
hippocampus. Particularly, age-associated increase of TNFa, IL-6
and CD11b mRNA expression was greatly reversed in the
hippocampus. This was accompanied by the restoration of
Figure 2. c-Fos expression in the DG, CA1 and CA3 regions of the hippocampus. c-Fos immunohistochemical analysis was performed in the
hippocampus of 3-month-old (young) and 22-month-old (aged) mice fed with the control diet or the LCv3 diet for 2 months and sacrificed 90 min
after the spatial recognition acquisition session. (A) Representative images of c-Fos immunohistochemistry in the DG (left panel), the CA1 (central
panel) and the CA3 region (right panel) of the hippocampus. Scale bar=100 mm. (B) Quantification of c-Fos-positive cells was performed in the DG,
the CA1 and the CA3 regions of the hippocampus. Data are presented as mean 6 SEM. ** p,0.01. (C) Correlation between the number of c-Fos
positive cells induced by the Y-maze task in the DG (left panel), the CA1 (central panel) and the CA3 (right panel) and the spatial recognition score.
Pearson’s correlation coefficients (r) and corresponding significance (p) are displayed within each correlation window. The number of c-Fos positive
cells in the DG and CA1, but not in the CA3 regions of the hippocampus was positively correlated to the spatial recognition score.
doi:10.1371/journal.pone.0036861.g002
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EPA and DHA to the diet could account for the improvement of
neuroinflammatory processes linked to aging since these lipids
have anti-inflammatory effects in the brain as shown by us and
others [28,53,57,58,59,60]. In our study, (GLA+EPA)/AA ratio
was increased in the brain of aged mice fed with the fish oil diet,
suggesting a balance in favor of anti-inflammatory prostaglandins
production in the brain [57]. However, the role of anti-
inflammatory prostaglandins remained to be determined. In
addition, the delta 5 desaturase index increased suggesting that
EPA did not limit synthesis of AA, as previously described in
humans [61]. Indeed, the efficacy of EPA and DHA supplemen-
tation in decreasing proinflammatory cytokines production in the
brain of aged mice could also be linked to other mediators such as
resolvins or neuroprotectins [62,63].
To our knowledge, this is the first evidence of the improvement
of astrocyte morphology by a short term dietary LCv3 PUFA
supplementation. Reactive astrocytes are normally characterized
by the overexpression of GFAP, the major component of astrocytic
cytoskeleton. Until recently, neuroinflammation-induced astro-
gliosis was described as a rise in the amount of GFAP and the
development of a hypertrophic phenotype [12]. Our data
confirmed the increase in GFAP expression already described in
the aged human and rodent brain. More importantly, by using
a 3D-reconstruction analysis, we showed a decrease in the length
of astrocytic processes in the DG, but not in the CA1 and CA3
regions of aged mice. This is in agreement with another recent
study, showing that the area occupied by GFAP-positive
structures, as measured by an unbiased stereological approach,
was reduced in the DG during aging, in spite of a better visibility
of these structures due to increased GFAP content [64].
Morphological modifications of astrocytes in this context were
dependent on proinflammatory cytokines. This change in the area
occupied by astrocytes, rather than their number, has thus been
Figure 3. Cytokine expression in the hippocampus and in plasma. (A) CD11b, GFAP, IL-1b, IL-6 and TNFa mRNA expression was measured by
real-time PCR in the hippocampus of 3-month-old (young) and 22-month-old (aged) mice fed with the control diet or the LCv3 diet for 2 months.
Data are presented as mean relative fold change 6 SEM. *** p,0.001, ** p,0.01, * p,0.05. (B) IL-1b, IL-6 and TNFa were measured by using
a multiplex cytokines assays in the plasma. Data are presented as mean 6 SEM in pg/ml. * p,0.05.
doi:10.1371/journal.pone.0036861.g003
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While the increase in GFAP mRNA expression was not reversed
by LCv3 PUFA supplementation in old mice in our study, the
length of astrocytic processes in the DG was restored, accompa-
nied by an increase in the astrocytic processes length in the CA1
and CA3 region of aged mice. In vitro, DHA influences astrocyte
morphology and function rather than GFAP expression, corrob-
orating our results [65,66]. In addition, a beneficial role for DHA
has been described in astrocyte maturation [66], which generally
involves changing from a flat epithelioid morphology to a process-
bearing stellate morphology [67]. Whether the effects of LCv3
PUFAs on astrocytes morphology in the hippocampus are direct
or mediated by cytokines remains to be elucidated. However,
knowing that LCv3 PUFAs have a strong impact on proin-
flammatory cytokines production in the brain [28,30] and that
proinflammatory cytokines, in particular IL-6, are produced by
and activate astrocytes [68,69,70], it is tempting to speculate that
the effects of LCv3 PUFAs on astrocytes morphology were linked
to their effects on neuroinflammation.
Of importance, aged mice fed with the control diet displayed
a decrease in spatial memory performances, as previously
described [10]. In addition, c-Fos was activated in the CA1 and
DG but not in the CA3 region of the hippocampus of young mice
after the Y-maze task, as the hippocampus processes spatial
information [42,71,72]. Interestingly, we found a decrease in c-Fos
activation in the CA1 and DG regions of the hippocampus of old
mice together with impaired Y-maze performances. The de-
creased expression of the activity-dependent immediate early
genes (IEGs) c-Fos and Arc with age has already been reported,
especially in the DG [73,74,75]. Given the role attributed to
Figure 4. Morphometry of astrocytic processes in the hippocampus. (A) Confocal analysis of GFAP immunofluorescence was performed in
the DG, the CA1 and the CA3 regions of the hippocampus of 3-month old (young) and 22-month old (aged) mice fed with the control diet or the
LCv3 diet for 2 months using a 63X oil-immersion lens with a 3.10X zoom and IMARIS software. Images are representative of GFAP 3D
immunofluorescence in the DG (upper panel), CA1 (central panel) and CA3 (lower panel). Scale bar=8.5 mm. (A) Morphometric analysis of astrocytes
in the DG, CA1 and CA3 regions of the hippocampus was performed using the ‘‘filament tracer’’ program/function. Data present means of primary
and secondary processes lengths expressed in mm 6 SEM. *** p,0.001, ** p,0.01, * p,0.05.
doi:10.1371/journal.pone.0036861.g004
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consolidation [43], it is likely that decreased c-Fos expression in
the DG was a contributing factor in the age-related decline in
hippocampal functions [77]. This was reinforced by the observa-
tion that alteration of the intrinsic properties or connectivity of the
DG (e.g. insults or genetic variability) has previously been related
to learning and memory deficits [78,79,80,81,82].
Several papers have reported the benefits of DHA and/or EPA
on behavior, in particular in aged rodents [55,83,84,85,86].
However, in most of these studies control mice were submitted to
an v3 PUFA deficient diet [55]. In our study, control mice were
fed with a control diet with a a-LNA/LA ratio of J. Very
importantly, short-term LCv3 PUFA supplementation did not
provide any cognitive benefits to young mice, but improved spatial
memory with a short retention time in old mice. These results
suggested that short-term DHA and EPA supplementation pro-
vided cognitive protection against spatial memory deficits linked to
age in mice fed with a diet containing EFA a-LNA and LA
throughout life. This was in accordance with recent studies
showing a positive effect of short-term dietary supplementation
with DHA and/or EPA on memory performances in aged mice
[34,37,87]. Conversely, other studies reported a lack of protective
effects of DHA/EPA-enriched diets on aged-associated cognitive
decline [31,34,88]. Such discrepancies could be linked to the
length of the supplementation time and the efficacy of LC PUFA
increase in brain cellular membranes. Few studies have addressed
the question of the duration of DHA dietary supplementation
necessary to achieve a beneficial effect on memory in aged rodents.
This would be of high interest in the context of age-associated
cognitive decline in humans, in which handling of dietary LCv3
PUFAs could offer an efficient strategy for sustaining cognitive
functions.
Indeed, increased level of EPA and DHA in the brain of aged
mice could account for the effects of fish oil supplementation on
spatial memory improvement. However, the mechanisms by
which LCv3 PUFAs reduced cognitive impairment in aged
rodents is not fully understood. According to our results, dietary
LC PUFAs decreased neuroinflammatory processes in the
hippocampus of old rodents. This was in accordance with previous
studies showing that dietary v3 PUFAs increased the recovery of
LTP while reducing microglial activation in old rodents
[89,90,91]. Of related interest was the prominent role played by
proinflammatory cytokines in inducing cognitive deficits in a model
of cerebral microvascular amyloid protein deposition, emphasized
by a study using minocycline, a tetracycline that inhibits microglial
activation [92]. This anti-inflammatory drug significantly im-
proved cognitive performances, along with a reduction in the
number of activated microglia and in IL-6 levels. In addition,
sulindac, an anti-inflammatory compound [93], as well as
minocycline improved learning and memory in a mouse model
of Alzheimer’s disease [25]. Importantly, minocycline partially
restores LTP and proinflammatory cytokines expression in the
hippocampus of middle-aged rats [24]. Very recently, neuroin-
flammatory processes have been identified as key early events
(occurring in midlife, together with age-related cognitive changes)
strongly implicated in cognitive dysfunction linked to age [23].
This is in accordance with results obtained in the lab (unpublished
data) and by others showing that inflammatory events first induce
production of proinflammatory cytokines in the hippocampus,
followed by impairments in spatial memory/learning [19].
In this context, one can wonder what would be the amount of
LCv3 PUFAs a human would have to consume to approximate
the supplementation given to mice in our study and its protective
effects. Epidemiological and clinical studies have used plasma and
erythrocyte membrane levels of LCv3 PUFAs as a surrogate
marker linking LC PUFAs status in the brain to cognitive disease
risks, but results remain contradictory [94,95]. To our knowledge,
the precise incorporation into the aged brain of LC PUFAs from
diet is not fully described. Recently, a study using positron
emission tomography reported that the brain incorporation rate of
DHA in form of free fatty acids is of 4.6 mg/day/1,500 g in
healthy human volunteers with no changes in patients suffering
from Alzheimer’s disease [96,97]. Further studies are therefore
needed to relate human brain rates of DHA incorporation to
dietary PUFA intake in aged subjects.
In conclusion, short-term LCv3 PUFA supplementation in aged
mice shut down low-grade neuroinflammation, restored astrocytes
morphology specifically in the DG region of the hippocampus and
improved hippocampus-dependent cognitive performance, strong-
ly supporting the view that dietary supplementation with LCv3
PUFAs could be used as a new therapeutic approach to prevent or
reduce age-linked cognitive impairment.
Supporting Information
Figure S1 Imaging, 3D reconstruction and morphomet-
ric analysis of astrocytes. (A) A series of consecutive 2D
sectional images with an interval of 0.5 mm in the z-axis was
collected with a confocal microscope using a 63X oil objective lens
with 3.10X zoom (Leica DMR upright TCS SP2 AOBS) and 3D
reconstruction was performed using IMARIS 64 Bitplane
software. Each astrocyte was then isolated using the crop 3D
function, and image processing, i.e. filtering of the images
(Gaussian filter), including the removal of background noise and
thresholding, was carried out, leading to B. (C) Morphometric
measurements were performed using the ‘‘filament tracer pro-
gram’’ (Matlab algorithm) allowing us to isolate each process of the
astrocyte (represented by different colors). (D) The length of an
astrocytic process was defined as the distance between the nucleus
and the tip of an extended process identified by GFAP
immunostaining. A Matlab algorithm was then used to produce
a 3D-reconstruction image and the mean diameter of each
astrocytic process.
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